openPR Logo
Press release

Curetis and Heraeus Medical Collaborate on the Development of New Unyvero™ Diagnostic Cartridge

09-28-2012 11:48 AM CET | Health & Medicine

Press release from: Curetis AG

/ PR Agency: akampion
- Joint development of cartridge for orthopaedics, wound and surgery infections -
Holzgerlingen and Wehrheim (Germany), September 20, 2012 -- Curetis AG and Heraeus Medical GmbH have signed a collaboration agreement to jointly develop a novel Unyvero™ cartridge for the detection of pathogens and antibiotic resistances in implant & tissue infections (ITI). One key application area will be in orthopaedics, e.g. to diagnose infections after knee and hip replacement surgeries.

Under the terms of the agreement, Heraeus and Curetis will co-fund product development in the respective indication areas. Heraeus’ customers will be given access to the Unyvero™ solution, while Curetis will pay a sales commission for any customer referrals by Heraeus to Curetis. No licenses are involved and further financial details were not disclosed.

Curetis will retain full control over its commercialization strategy and execution both directly in the DACH region as well as via its international distributor network. The resulting Unyvero cartridge and application will be a Curetis-labeled IVD.

The collaboration will provide Heraeus with access to leading-edge, innovative and easy-to-use in vitro diagnostics and molecular diagnostic solutions for its customers. The new ITI cartridge will be of interest not only in general surgery, but also in infections caused by biofilms (e.g. on knee and hip implants or catheters), in abdominal surgery infections, diabetic foot, burn wounds etc.

Today, wound and surgical site infections are increasingly caused by bacteria carrying multiple antibiotic resistances. In orthopaedic indications, infections often involve biofilms, communities of microorganisms very hard to open up and cultivate. At present, it may take 7-15 days to obtain results from biofilm samples. This scenario often leads to prolonged empiric treatment, follow-on surgeries and increased morbidity and healthcare costs.

For the development of the new cartridge, the partners have jointly conducted market research in orthopaedic applications throughout Europe. They have also teamed up with clinical key opinion leaders in Germany, Switzerland, France, the UK, and Scandinavia to determine the pathogens and antibiotic resistances that need to be included in the diagnostic panel of the new cartridge. The partners expect assay development for the new cartridge to be completed by early 2013, with clinical validation and CE marking throughout 2013 and an expected launch in the EU by the end of 2013. The product is likely to include more than 40 and possibly up to 50 analytes.

“There is a need for a highly accurate implant/orthopaedic infection test for mixed pathogens; the diagnostic field is for Heraeus Medical – a leader in infection management in orthopaedics - an extension of its core business,” said André Kobelt, CEO of Heraeus Medical GmbH. “Therefore, we are happy to team up with Curetis as the Unyvero platform provides customers with superior molecular diagnostics solutions to combat serious infections faster and more effectively, as well as potentially improving the management of latent orthopaedic infection.”

“The collaboration with Heraeus Medical provides us with the opportunity to leveraging our Unyvero platform once again in an important indication, which is only poorly addressed by today’s diagnostic tools,” said Oliver Schacht, CEO of Curetis. “We offer highly multiplexed analyte panels of pathogens and resistance markers for applications that require the ability to work with a diverse set of native, complex clinical samples and an unmatched ease of use from sample-to-result in about 4 hours. The collaboration is in line with our goal of maintaining full strategic and commercial freedom in our partnerships.”

###

About the Unyvero™ System
The CE-marked Unyvero™ System is a versatile hardware platform for the detection of a broad panel of bacteria and antibiotic resistances from a single sample in one run. It processes a disposable cartridge providing the necessary reagents to complete the analysis from sample to result.
The platform enables the DNA-based testing of all clinically relevant samples in a fully automated, unsupervised analysis process requiring only few, quick manual preparation steps. The analysis thus can be performed with minimal operator time and without the need of skilled staff or special infrastructure. Thereby, clinically relevant information is available within about four hours to support an informed therapy decision as early as possible.
The first CE-marked Unyvero™ Cartridge, Unyvero™ P50, focuses on pneumonia testing and simultaneously analyses 39 DNA targets. Cartridges for further applications, e.g. for surgical site infections, blood stream infections and tuberculosis, are in preparation.

About Heraeus
Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with more than 160 years of tradition. The fields of competence include precious metals, materials, and technologies, sensors, biomaterials, and medical products, as well as dental products, quartz glass, and specialty light sources. With product revenues of €4.8 billion and precious metal trading revenues of €21.3 billion, as well as more than 13,300 employees in over 120 subsidiaries worldwide, Heraeus holds a leading position in its global markets.
Heraeus Medical develops, manufactures and markets biomaterials and accessories to make an essential contribution to improving surgical results in bone and joint surgery as well as infection management.

Contact
Curetis AG
Max-Eyth-Str. 42
71088 Holzgerlingen, Germany
Tel. +49 (0) 7031 49195-10
pr(at)curetis.com
www.curetis.com

Heraeus Medical GmbH
Philipp-Reis-Str. 8/13
61273 Wehrheim, Germany
Tel. +49 (0) 6181 – 35 33 99
www.heraeus-medical.com

Media Inquiries
akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info(at)akampion.com
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68

About Curetis AG
Founded in 2007, Curetis AG is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis AG will enable rapid multiparameter pathogen and antibiotic resistance detection in only a few hours, a process that today can take up to days or even weeks with other techniques. To date, Curetis has raised total funds of over € 36.6 million (~ USD 50 million). The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Sanofi Pasteur, Heraeus Medical and Cempra Inc., as well as several international distribution agreements.

Curetis AG
Oliver Schacht, CEO

Max-Eyth-Str. 42
71088 Holzgerlingen, Germany
Tel. +49 (0) 7031 49195-10
pr(at)curetis.com
www.curetis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Curetis and Heraeus Medical Collaborate on the Development of New Unyvero™ Diagnostic Cartridge here

News-ID: 236833 • Views: 5832

More Releases from Curetis AG

Mayo Clinic’s Dr. Robin Patel Named Principal Investigator for Curetis’ Unyv …
− Curetis adds six new trial sites, significantly expanding U.S. clinical trial network for ongoing FDA study Holzgerlingen, Germany, May 14, 2014 -- Curetis AG, a developer of next-level molecular diagnostic solutions, today announced that Robin Patel, M.D., Professor of Medicine and Microbiology at the Mayo Clinic in Rochester, Minn., has been named Lead Principal Investigator of the company’s Unyvero™ LRT Application FDA trial. The lower respiratory tract (LRT) application is
Curetis AG Initiates Clinical Trial in the U.S. Towards FDA Clearance
- Prospective Multi-Center Trial to Enroll Over 2,000 Clinical Samples - Holzgerlingen, Germany, December 6, 2012 -- Curetis AG today announced the start of a clinical trial of its Unyvero™ System and the corresponding LRT (lower respiratory tract) application in the U.S. The company expects enrollment completion within the next 12-15 months, followed by a 510(k) submission to the FDA in 2014. The prospective, multicenter trial will include samples collected from more
Curetis and Scholz Collaborate to Industrialize and Scale-Up Production of Unyve …
- German family firm ‘Scholz-HTIK – High Tech in Kunststoff’ has been selected by Curetis based on systematic benchmarking process - Holzgerlingen (Germany), December 4, 2012 -- Curetis AG today announced a strategic supply chain partnership with German family business Horst Scholz GmbH + Co. KG for the production of high-quality plastics parts for its Unyvero™ Cartridge. Under the agreement, Curetis will invest more than € 2 million in multi-cavity tools for
Curetis Completes Enrollment for its EU Trial As Planned
- Prospective multi-center trial enrolls 800 patient samples in 7 months - Holzgerlingen (Germany), October 9, 2012 -- Curetis AG today announced it has completed enrollment for the European clinical trial of its Unyvero™ Pneumonia Application on schedule. More than 800 patient samples were collected until September 30, 2012. Data analysis will be completed in early 2013. Subsequently, results will be published in a major, peer-reviewed journal. The trial will compare the

All 5 Releases


More Releases for Heraeus

Sputter Coating Market 2020 Competitive Insights- Honeywell, Materion, ULVAC, He …
The Global Sputter Coating Market research report primarily aims to hint at opportunities and challenges in the Global industry. The report also underscores potential risks, threats, obstacles, and uncertainties in the market and helps clients in intuiting them precisely and operating their business accordingly. The report covers an extensive span of the global Sputter Coating market ranging from historical and current events to futuristic stich of the market. Click the link
Global Silver Paste Market 2018 - Dupont, Heraeus, Noritake, Giga Solar
The statistical surveying information incorporated into the Silver Paste report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Silver Paste based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Silver Paste advertise covering key factors, for example, drivers and
Conducting Polymers Market 2017- 3M, PolyOne, Heraeus, Celanese, Henkel, Solvay
Apex Market Reports, recently published a detailed market research study focused on the "Conducting Polymers Market" across the global, regional and country level. The report provides 360° analysis of "Conducting Polymers Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Conducting Polymers industry, and estimates the future trend of Conducting Polymers market
Heraeus Implements JAGGAER eProcurement Solution
VIENNA, AUSTRIA – September 07, 2017 – JAGGAER, producers of the world's most comprehensive Source to Pay (S2P) solutions suite, today announced that Heraeus, a leading international technology group based out of Hanau, Germany, has implemented JAGGAER’s eProcurement software solution to standardize and digitize its procurement process. “In addition to the value we gain in updating our procurement platform using JAGGAER’s comprehensive procurement software, we plan for future expansion of our
Bonding Wires Market 2017 -AFL, KITCO, AMETEK, Airproducts, Heraeus Holding
Apex Research, recently published a detailed market research study focused on the "Bonding Wires Market" across the global, regional and country level. The report provides 360° analysis of "Bonding Wires Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Bonding Wires industry, and estimates the future trend of Bonding Wires market on
Global Quartz Glass Market Research Report 2017 - Heraeus, Tosoh, Momentive
Qyresearchreports include new market research report "Global Quartz Glass Market Research Report 2017" to its huge collection of research reports. The global market for Quartz Glass has been manifested on several dynamics that are on the verge or have already impacted the growth of the market in several contexts. The report further voices different statistics and data pertaining to the global Quartz Glass market. The core aim of the report is